Virothera Pharmaceuticals

Virothera is a biotechnology company focused on the discovery and development of novel small molecule antiviral therapies to treat high-impact respiratory viral infections. The company's primary research efforts target essential viral replication enzymes to create broad-spectrum treatments for influenza, COVID-19, and respiratory syncytial virus (RSV). By leveraging a deep understanding of viral structure and function, Virothera aims to develop potent inhibitors that can overcome drug resistance and provide effective clinical outcomes. The company is currently in the pre-clinical stage, advancing its lead candidates through optimization and safety profiling.